Mural Oncology (MURA) Earnings Date & Reports

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MURA is expected to report earnings to fall 1.49% to -198 cents per share on May 20

Mural Oncology MURA Stock Earnings Reports

Q1'25

Est.

$-1.98

Q4'24

Missed

by $0.02

Q3'24

Beat

by $0.10

Q2'24

Beat

by $0.09

Q1'24

Beat

by $0.82

The last earnings report on March 11 showed earnings per share of -200 cents, missing the estimate of -199 cents. With 320.50K shares outstanding, the current market capitalization sits at 21.36M.

View a ticker or compare two or three

Compare

MURA